Pap smear and cervical cancer in transgender men: integrative review
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Research, Society and Development |
Texto Completo: | https://rsdjournal.org/index.php/rsd/article/view/12342 |
Resumo: | Introduction: Pap smear is the main screening method for cervical cancer, which can affect transgender men who have this organ. Objective: To highlight the importance of cytopathological examination in the fight against cervical cancer in transgender men. Methodology: It is an integrative literature review of a descriptive nature and qualitative approach, carried out on the SciELO, PUBMED, MEDLINE, LILACS, VHL and Science Direct databases, using the descriptors "Transgender Persons", "Uterine Cervical Neoplasms" and "Papanicolaou Test". Articles from 2015 to 2020 that address Pap smear and cervical cancer or cancer precursor lesions in transgender men were included. The analysis took place through critical reading and thematic categorization. Results and discussion: Eight articles were found that originated three categories: Screening for cervical cancer in transgender men, history related to the Pap smear and perceptions about screening for cervical cancer. Thus, it was found that transgender men do not screen for cervical cancer like cisgender women and face unique challenges in the Pap smear, relevant to each reality, leading them to seek alternatives that minimize their discomfort. Conclusion: The data reveal the importance of the Pap smear in the screening of cervical cancer in transgender men, since compared to alternative means sought, it is the most reliable today. Still, they reinforce the need for knowledge for individualized screening in this audience. |
id |
UNIFEI_404b27339b72f1b5b950ba8516adbbd8 |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/12342 |
network_acronym_str |
UNIFEI |
network_name_str |
Research, Society and Development |
repository_id_str |
|
spelling |
Pap smear and cervical cancer in transgender men: integrative reviewPrueba de Papanicolaou y cáncer de cuello uterino en hombres transgéneros: revisión integradoraExame de Papanicolaou e câncer cervical em homens transgêneros: revisão integrativaTransgender personsUterine cervical neoplasmsPapanicolaou test. Personas transgéneroNeoplasias del cuello uterinoPrueba de Papanicolaou. Pessoas transgêneroNeoplasias do colo do úteroTeste de Papanicolaou.Introduction: Pap smear is the main screening method for cervical cancer, which can affect transgender men who have this organ. Objective: To highlight the importance of cytopathological examination in the fight against cervical cancer in transgender men. Methodology: It is an integrative literature review of a descriptive nature and qualitative approach, carried out on the SciELO, PUBMED, MEDLINE, LILACS, VHL and Science Direct databases, using the descriptors "Transgender Persons", "Uterine Cervical Neoplasms" and "Papanicolaou Test". Articles from 2015 to 2020 that address Pap smear and cervical cancer or cancer precursor lesions in transgender men were included. The analysis took place through critical reading and thematic categorization. Results and discussion: Eight articles were found that originated three categories: Screening for cervical cancer in transgender men, history related to the Pap smear and perceptions about screening for cervical cancer. Thus, it was found that transgender men do not screen for cervical cancer like cisgender women and face unique challenges in the Pap smear, relevant to each reality, leading them to seek alternatives that minimize their discomfort. Conclusion: The data reveal the importance of the Pap smear in the screening of cervical cancer in transgender men, since compared to alternative means sought, it is the most reliable today. Still, they reinforce the need for knowledge for individualized screening in this audience.Introducción: La prueba de Papanicolaou es el principal método de detección del cáncer de cuello uterino, que puede afectar a los hombres transgénero que tienen este órgano. Objetivo: Resaltar la importancia del examen citopatológico en la lucha contra el cáncer de cuello uterino en hombres transgénero. Metodología: Es una revisión integradora de la literatura de carácter descriptivo y abordaje cualitativo, realizada sobre las bases de datos SciELO, PUBMED, MEDLINE, LILACS, VHL y Science Direct, utilizando los descriptores "Personas Trans", "Neoplasias del Cuello Uterino" y "Prueba de Papanicolaou". Se incluyeron artículos de 2015 a 2020 que abordan el Papanicolaou y el cáncer de cuello uterino o las lesiones precursoras del cáncer en hombres transgénero. El análisis se realizó mediante lectura crítica y categorización temática. Resultados y discusión: Se encontraron ocho artículos que originaron tres categorías: Detección de cáncer de cuello uterino en hombres transgénero, antecedentes relacionados con la prueba de Papanicolaou y percepciones sobre la detección de cáncer de cuello uterino. Así, se encontró que los hombres transgénero no realizan cribado de cáncer de cuello uterino como las mujeres cisgénero y enfrentan desafíos únicos en el examen de Papanicolaou, relevantes para cada realidad, lo que los lleva a buscar alternativas que minimicen su malestar. Conclusión: Los datos revelan la importancia de la prueba de Papanicolaou en el cribado de cáncer de cuello uterino en hombres transgénero, ya que en comparación con los medios alternativos buscados, es el más confiable en la actualidad. Aún así, refuerzan la necesidad de conocimiento para una proyección individualizada en esta audiencia.Introdução: O exame de Papanicolaou é o principal método de rastreamento para o câncer do colo do útero, que pode acometer os homens transgêneros que apresentam esse órgão. Objetivo: Destacar a importância do exame citopatológico no combate ao câncer cervical em homens transgêneros. Metodologia: Trata-se de uma revisão integrativa da literatura de cunho descritivo e abordagem qualitativa, realizada nas bases SciELO, PUBMED, MEDLINE, LILACS, BVS e Science Direct, utilizando os descritores “Transgender Persons”, “Uterine Cervical Neoplasms” e “Papanicolaou Test”. Foram incluídos artigos de 2015 a 2020 que abordam sobre o exame de Papanicolaou, e o câncer do colo do útero ou lesões precursoras do câncer em homens transgêneros. A análise ocorreu através de leitura crítica e categorização temática. Resultados e discussão: Foram encontrados oito artigos que originaram três categorias: Rastreamento do câncer cervical em homens transgêneros, histórico relacionado ao exame de Papanicolaou e percepções sobre o rastreamento do câncer cervical. Assim, constatou-se que os homens transgêneros não realizam rastreamento do câncer cervical como as mulheres cisgêneros e enfrentam desafios únicos no exame de Papanicolaou, pertinentes a cada realidade, levando-os a buscar alternativas que minimizem seus desconfortos. Conclusão: Os dados revelam a importância do exame de Papanicolaou no rastreamento do câncer cervical em homens transgêneros, visto que comparado a meios alternativos buscados, o mesmo é o mais confiável atualmente. Ainda, reforçam a necessidade de conhecimento para um rastreamento de forma individualizada nesse público.Research, Society and Development2021-02-09info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/1234210.33448/rsd-v10i2.12342Research, Society and Development; Vol. 10 No. 2; e17010212342Research, Society and Development; Vol. 10 Núm. 2; e17010212342Research, Society and Development; v. 10 n. 2; e170102123422525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/12342/11106Copyright (c) 2021 Jéssica Mayara da Silva Araújo; Maria Mylena Gomes Santos; Renata Santos da Silva; Manuela de Carvalho Vieira Martins; Fernanda Costa Martins Gallottihttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessAraújo, Jéssica Mayara da Silva Santos, Maria Mylena Gomes Silva, Renata Santos da Martins, Manuela de Carvalho VieiraGallotti, Fernanda Costa Martins 2021-03-02T09:32:39Zoai:ojs.pkp.sfu.ca:article/12342Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:33:56.726752Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false |
dc.title.none.fl_str_mv |
Pap smear and cervical cancer in transgender men: integrative review Prueba de Papanicolaou y cáncer de cuello uterino en hombres transgéneros: revisión integradora Exame de Papanicolaou e câncer cervical em homens transgêneros: revisão integrativa |
title |
Pap smear and cervical cancer in transgender men: integrative review |
spellingShingle |
Pap smear and cervical cancer in transgender men: integrative review Araújo, Jéssica Mayara da Silva Transgender persons Uterine cervical neoplasms Papanicolaou test. Personas transgénero Neoplasias del cuello uterino Prueba de Papanicolaou. Pessoas transgênero Neoplasias do colo do útero Teste de Papanicolaou. |
title_short |
Pap smear and cervical cancer in transgender men: integrative review |
title_full |
Pap smear and cervical cancer in transgender men: integrative review |
title_fullStr |
Pap smear and cervical cancer in transgender men: integrative review |
title_full_unstemmed |
Pap smear and cervical cancer in transgender men: integrative review |
title_sort |
Pap smear and cervical cancer in transgender men: integrative review |
author |
Araújo, Jéssica Mayara da Silva |
author_facet |
Araújo, Jéssica Mayara da Silva Santos, Maria Mylena Gomes Silva, Renata Santos da Martins, Manuela de Carvalho Vieira Gallotti, Fernanda Costa Martins |
author_role |
author |
author2 |
Santos, Maria Mylena Gomes Silva, Renata Santos da Martins, Manuela de Carvalho Vieira Gallotti, Fernanda Costa Martins |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
Araújo, Jéssica Mayara da Silva Santos, Maria Mylena Gomes Silva, Renata Santos da Martins, Manuela de Carvalho Vieira Gallotti, Fernanda Costa Martins |
dc.subject.por.fl_str_mv |
Transgender persons Uterine cervical neoplasms Papanicolaou test. Personas transgénero Neoplasias del cuello uterino Prueba de Papanicolaou. Pessoas transgênero Neoplasias do colo do útero Teste de Papanicolaou. |
topic |
Transgender persons Uterine cervical neoplasms Papanicolaou test. Personas transgénero Neoplasias del cuello uterino Prueba de Papanicolaou. Pessoas transgênero Neoplasias do colo do útero Teste de Papanicolaou. |
description |
Introduction: Pap smear is the main screening method for cervical cancer, which can affect transgender men who have this organ. Objective: To highlight the importance of cytopathological examination in the fight against cervical cancer in transgender men. Methodology: It is an integrative literature review of a descriptive nature and qualitative approach, carried out on the SciELO, PUBMED, MEDLINE, LILACS, VHL and Science Direct databases, using the descriptors "Transgender Persons", "Uterine Cervical Neoplasms" and "Papanicolaou Test". Articles from 2015 to 2020 that address Pap smear and cervical cancer or cancer precursor lesions in transgender men were included. The analysis took place through critical reading and thematic categorization. Results and discussion: Eight articles were found that originated three categories: Screening for cervical cancer in transgender men, history related to the Pap smear and perceptions about screening for cervical cancer. Thus, it was found that transgender men do not screen for cervical cancer like cisgender women and face unique challenges in the Pap smear, relevant to each reality, leading them to seek alternatives that minimize their discomfort. Conclusion: The data reveal the importance of the Pap smear in the screening of cervical cancer in transgender men, since compared to alternative means sought, it is the most reliable today. Still, they reinforce the need for knowledge for individualized screening in this audience. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-02-09 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/12342 10.33448/rsd-v10i2.12342 |
url |
https://rsdjournal.org/index.php/rsd/article/view/12342 |
identifier_str_mv |
10.33448/rsd-v10i2.12342 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/12342/11106 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Research, Society and Development |
publisher.none.fl_str_mv |
Research, Society and Development |
dc.source.none.fl_str_mv |
Research, Society and Development; Vol. 10 No. 2; e17010212342 Research, Society and Development; Vol. 10 Núm. 2; e17010212342 Research, Society and Development; v. 10 n. 2; e17010212342 2525-3409 reponame:Research, Society and Development instname:Universidade Federal de Itajubá (UNIFEI) instacron:UNIFEI |
instname_str |
Universidade Federal de Itajubá (UNIFEI) |
instacron_str |
UNIFEI |
institution |
UNIFEI |
reponame_str |
Research, Society and Development |
collection |
Research, Society and Development |
repository.name.fl_str_mv |
Research, Society and Development - Universidade Federal de Itajubá (UNIFEI) |
repository.mail.fl_str_mv |
rsd.articles@gmail.com |
_version_ |
1797052669639000064 |